Company news

Abbott Laboratories news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

November 1, 2026

Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease

October 29, 2026

Abbott Laboratories receives FDA approval for first and only device in the U.S. to treat leaks after heart valve replacement without additional surgery

October 28, 2026

Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment

October 26, 2026

Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer

October 23, 2026

Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance

October 21, 2026

Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company

October 21, 2026

Abbott's Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe

October 20, 2026

Abbott Laboratories Reports New Real-World Evidence Linking Cologuard Screening to Lower Colorectal Cancer Incidence and Odds of Death

October 12, 2026

Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop

October 7, 2026

Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition

October 5, 2026

Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio

September 30, 2026

Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications

September 24, 2026

Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health

September 23, 2026

Abbott declares 411th consecutive quarterly dividend

September 17, 2026

First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care

September 15, 2026

Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall

September 14, 2026

Abbott and Sengkang General Hospital expand partnership to advance early detection of muscle loss and support healthy aging

September 9, 2026

Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms

September 8, 2026

Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula

August 31, 2026

Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke

August 27, 2026

Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

August 26, 2026

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes

August 25, 2026

James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician

August 24, 2026

Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants

August 20, 2026

Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare

August 17, 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

August 12, 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

August 11, 2026

Abbott Laboratories initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve

July 28, 2026

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

July 16, 2026

Abbott hosts conference call for second-quarter earnings

June 25, 2026

New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents

June 22, 2026

Abbott declares 410th consecutive quarterly dividend

June 12, 2026

New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

June 8, 2026

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

June 6, 2026

Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

May 27, 2026

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

May 27, 2026

Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026

May 26, 2026

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

May 18, 2026

Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh

May 18, 2026

Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo

May 18, 2026

Abbott, Stringham & Lynch Announces Acquisition of Finance and Accounting Solutions Firm, ArightCo

May 14, 2026

Australia Regenerative Medicine Market Research Trends and Forecasts Report 2026-2035 Featuring Prominent Players Such as Abbott Laboratories, Astellas Pharma, and Roche

May 13, 2026

Timothy P. Walbert Joins Patient Square Capital as a Senior Advisor

May 6, 2026

GLP-1 Hydration Products Market Outlook 2036 with Key Contributions from Smoothie King, Liquid I.V., Electrolit, Abbott, Nestlé Health Science, and ADM | Future Market Insights

May 5, 2026

Abbott Laboratories to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026

April 30, 2026

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

April 28, 2026

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

April 25, 2026

Catheters Market Report 2025-2030, Profiles and Strategy Analysis of Leading Players - Abbott Laboratories, Boston Scientific, Medtronic, Terumo, and B. Braun

April 23, 2026

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

April 17, 2026

Older news releases →

Calls

The 5 newest of 32 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.